Sun Pharmaceutical Industries

Ultime notizie

Titoli nella lingua originale della fonte.

• 
  Sun Pharma Announces LEQSELVI Safety and Efficacy Findings at EADV 2026 (si apre in una nuova scheda)

  Medical Dialogues · 3 ott 2026

• Sun Pharma and LIB Therapeutics Sign Lerodalcibep Agreement (si apre in una nuova scheda)

  Machine Maker · 3 ott 2026

• Sun Pharma’s LEQSELVI shows sustained hair regrowth through two years (si apre in una nuova scheda)

  Indian Pharma Post · 2 ott 2026

• Pfizer Sues Sun Pharmaceutical to Block Copies of Cancer Drug (si apre in una nuova scheda)

  Bloomberg Law News · 2 ott 2026

• Sun Pharma's Leqselvi shows sustained hair regrowth through two years in alopecia areata (si apre in una nuova scheda)

  The Pharma Letter · 2 ott 2026

• Sun Pharma's US Business Under Pressure: Can New Launches Drive a Recovery? (si apre in una nuova scheda)

  Trade Brains · 2 ott 2026

• Sun Pharma Publishes Postal Ballot and E-Voting Notices for Shareholders (si apre in una nuova scheda)

  TipRanks · 2 ott 2026

• Sun Pharma Postal Ballot Notice October 2026 (si apre in una nuova scheda)

  Kalkine India · 2 ott 2026

• Sun Pharma seeks approval for ESOP 2026 and ₹700 billion borrowing limit (si apre in una nuova scheda)

  scanx.trade · 1 ott 2026

• Sun Pharma (NSE: SUNPHARMA) Secures Global Rights for Lerodalcibep Outside the US and China (si apre in una nuova scheda)

  Kalkine India · 1 ott 2026

• Sun Pharma reports sustained LEQSELVI efficacy in two-year alopecia study (si apre in una nuova scheda)

  scanx.trade · 1 ott 2026

• Sun Pharmaceutical Industries slips Thursday, still outperforms market (si apre in una nuova scheda)

  MarketWatch · 1 ott 2026

• Sun Pharma’s Biggest Global Bet, Buys Organon in $11.75 Billion Deal; Pharma Stock Surge 7% - Time to Buy? (si apre in una nuova scheda)

  Goodreturns · 1 ott 2026

• Sun Pharmaceutical Industries slips Wednesday, underperforms market (si apre in una nuova scheda)

  MarketWatch · 30 set 2026

• India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say (si apre in una nuova scheda)

  Reuters · 29 set 2026

• Sun Pharmaceutical Industries rises Tuesday, outperforms market (si apre in una nuova scheda)

  MarketWatch · 29 set 2026

• LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a Novel PCSK9 Inhibitor, Ex-US and China; Lerodalcibep (Lyrokaul®) Approved in the EU (si apre in una nuova scheda)

  businesswire.com · 28 set 2026

• Sun Pharmaceutical Industries falls Monday, underperforms competitors (si apre in una nuova scheda)

  MarketWatch · 28 set 2026

• Sun Pharmaceutical Industries (NSEI:SUNPHARMA) Stock Forecast & Analyst Predictions (si apre in una nuova scheda)

  Simply Wall Street · 28 set 2026

• Sun Pharma in focus after tapping into $3.7 Billion ex-US/China PCSK9 inhibitor market (si apre in una nuova scheda)

  Trade Brains · 28 set 2026

• Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Secures Lerodalcibep Rights Across Global Markets (si apre in una nuova scheda)

  Kalkine India · 28 set 2026

• Sun Pharma inks global licensing pact with LIB Therapeutics for cholesterol drug Lerodalcibep (si apre in una nuova scheda)

  Daily Excelsior · 28 set 2026

• Sun Pharma shareholders approve reclassification of promoters to public (si apre in una nuova scheda)

  scanx.trade · 26 set 2026

• Sun Pharmaceutical Industries rises Friday, underperforms competitors (si apre in una nuova scheda)

  MarketWatch · 25 set 2026

• Sun Pharma के शेयर में हल्की बढ़त, ILUMYA के नए arthritis उपयोग की US FDA समीक्षा मंजूरी के बाद। (si apre in una nuova scheda)

  Alice Blue · 24 set 2026

• Sun Pharma Investor Presentation: Growth, Market Leadership & Strategy (si apre in una nuova scheda)

  investywise.com · 22 set 2026

• Sun Pharmaceutical Industries falls Tuesday, underperforms market (si apre in una nuova scheda)

  MarketWatch · 22 set 2026

• Sun Pharma FY26 Results: Net profit up 5% YoY to ₹11,479 crore (si apre in una nuova scheda)

  scanx.trade · 22 set 2026

• Brokerage ‘Buy’ Calls: Phoenix Mills To Sun Pharma; Top 4 Stocks With Up To 30% Uptick Potential (si apre in una nuova scheda)

  The Daily Jagran · 21 set 2026

• Buy Sun Pharmaceutical Industries; target of Rs 2070: Geojit Financial Services (si apre in una nuova scheda)

  Moneycontrol.com · 21 set 2026